Exponent
EXPO · NASDAQ
About EXPO
- Employees
- 1,212
- Headquarters
- Menlo Park, California
- Listed
- Aug 17, 1990
- Sector
- Industrials
- Industry
- Professional Services
- Website
- exponent.com
EXPO key statistics
- Market cap
- 3.45B
- Price-earnings ratio
- 32.40
- Dividend yield
- 1.78%
- Average volume
- 557.94K
- Volume
- 787.43K
- Open price
- $73.00
- High today
- $73.83
- Low today
- $72.15
- 52 Week high
- $81.95
- 52 Week low
- $51.91
Exponent (EXPO) at a glance
As of Oct 20, 2026, Exponent (EXPO) shares are priced at $72.55, giving the company a market cap of 3.45B, a price-to-earnings ratio of 32.40 and a dividend yield of 1.78%.
Today the stock has traded between $72.15 and $73.83. The current price is 0.6% above the day's low and 1.7% below its high.
Volume so far is 787.43K shares, above the average of 557.94K shares a day.
Over the past year Exponent has ranged from $51.91 to $81.95, and now sits 69% of the way up that range.
Exponent met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.60 per share against an estimate of $0.561.
The average analyst price target is $82.62, 13.9% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy66.7%
- Hold33.3%
- Sell0.0%
- Low
- $72.72
- Now
- $72.55
- High
- $94.50
EXPO earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 5.1% on average.
- Q3 FY24: reported $0.50 per share against an estimate of $0.4896
- Q4 FY24: reported $0.46 per share against an estimate of $0.4114
- Q1 FY25: reported $0.52 per share against an estimate of $0.4896
- Q2 FY25: reported $0.52 per share against an estimate of $0.5032
- Q3 FY25: reported $0.55 per share against an estimate of $0.5168
- Q4 FY25: reported $0.59 per share against an estimate of $0.5789
- Q1 FY26: reported $0.59 per share against an estimate of $0.5789
- Q2 FY26: reported $0.60 per share against an estimate of $0.561
EXPO news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Exponent Declares Regular Quarterly Dividend for Q3 2026 and Increases Stock Repurchase Authorization by $50 Million
- Press releaseGlobe Newswire
Exponent Declares Regular Quarterly Dividend for Q2 2026 and Increases Stock Repurchase Authorization by $50 Million
- Press releaseGlobe Newswire
Exponent Reports First Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to Board of Directors
- Press releaseGlobe Newswire
Exponent Reports Fourth Quarter and Fiscal Year 2025 Financial Results
- Press releaseGlobe Newswire
Exponent Increases Quarterly Dividend Payment from $0.30 to $0.31 per Share for Q1 2026
Earnings Scheduled For February 5, 2026
Similar companies
Companies in the same industry as Exponent
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.